glp 1 gip tirzepatide Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Understanding Compounded Tirzepatide and Its

Your INR needs closer monitoring

Tirzepatide for T2D obesity SURMOUNT-2, weight -12.8/-14.7% at 10/15 mg, attenuated about 6-7 points vs non-diabetic obesity: Garvey Lancet 2023

The medication is not recommended during pregnancy, and women of reproductive potential should be counseled about potential risks

These include: Patients currently taking another GLP-1 medication cannot take semaglutide at the same time, though they may be able to switch under provider supervision

How does semaglutide dose titration work

Novel anti-obesity medications, including Tirzepatide and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), have demonstrated effective weight reduction and glycemic control 11,12,13